The binding site of the cyclic peptide antibiotics capreomycin and viomycin is located on the ribosomal subunit interface close to nucleotides C1409 in 16S rRNA and C1920 in 23S rRNA. In Mycobacterium tuberculosis, the 2´-hydroxyls of both nucleotides are methylated by the enzyme TlyA. Loss of these methylations through inactivation of TlyA confers resistance to capreomycin and viomycin (1). We report here that TlyA orthologs occur in diverse bacteria and fall into two distinct groups. One group, now termed TlyA I , has shorter N-and Ctermini and methylates only C1920; the second group (now TlyA II ) includes the mycobacterial enzyme, and these longer orthologs methylate at both C1409 and C1920 (2, 3). Ribosomal subunits are the preferred substrates for both groups of orthologs. Amino acid substitutions at the N-terminus of TlyA II reduce its ability to methylate these substrates. Growing pairs of recombinant TlyA II Escherichia coli strains in competition shows that even subtle changes in the level of rRNA methylation lead to significant differences in susceptibility to sub-inhibitory concentrations of capreomycin. The findings reveal that 2´-O-methyls at both C1409 and C1920 play a role in facilitating the inhibitory effects of capreomycin and viomycin on the bacterial ribosome (3). 
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